Artra Group Corporation (6029.T)
- Previous Close
154.00 - Open
155.00 - Bid 157.00 x --
- Ask 158.00 x --
- Day's Range
155.00 - 161.00 - 52 Week Range
101.00 - 222.00 - Volume
255,400 - Avg. Volume
1,604,858 - Market Cap (intraday)
1.612B - Beta (5Y Monthly) 0.20
- PE Ratio (TTM)
-- - EPS (TTM)
-3.59 - Earnings Date Aug 6, 2025 - Aug 11, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Dec 29, 2021
- 1y Target Est
--
Artra Group Corporation provides support services for acupuncture, moxibustion, and orthopedic clinics in Japan. It operates through two segments, Acupuncture and Moxibustion Hospital Support Business, and Toy Sales Business. The company offers billing services; and HONEY-STYLE, a word-of-mouth / reservation system for acupuncture and moxibustion clinics. It also operates Atlas Store, an EC site that sells consumables for acupuncture and moxibustion hospital; and operates fitness club, as well as offers long-term care support services. In addition, the company sells equipment and consumables; fitness mirrors; and toys, stationery, etc. The company was formerly known as artra corporation and changed its name to Artra Group Corporation in 2021. Artra Group Corporation was incorporated in 2005 and is headquartered in Osaka, Japan.
www.artra-group.co.jp142
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 6029.T
View MorePerformance Overview: 6029.T
Trailing total returns as of 5/26/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 6029.T
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 6029.T
View MoreValuation Measures
Market Cap
1.58B
Enterprise Value
1.81B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.37
Price/Book (mrq)
1.10
Enterprise Value/Revenue
0.43
Enterprise Value/EBITDA
12.33
Financial Highlights
Profitability and Income Statement
Profit Margin
-0.50%
Return on Assets (ttm)
0.20%
Return on Equity (ttm)
-1.48%
Revenue (ttm)
4.17B
Net Income Avi to Common (ttm)
-21M
Diluted EPS (ttm)
-3.59
Balance Sheet and Cash Flow
Total Cash (mrq)
1.02B
Total Debt/Equity (mrq)
88.64%
Levered Free Cash Flow (ttm)
--